CSF-1R inhibition was able to block TAM polarization in mouse models of T-acute lymphoblastic leukemia (ALL) and the association between a CSF-1R inhibitor and vincristine could increase survival of leukemic mice, if compared to vincristine as monotherapy [129]. The gene discussed is CSF1R; the disease is acute lymphoblastic leukemia.